It takes 15 years to develop new drugs. Companies want to improve the critical path. From the compound selection to its final certification for clinical use.
The use of imaging is becoming more critical to show success of new drugs as they show the effects of the trial drugs quicker than traditional physical diagnostics.
Hospitals become part of the trail and are contracted as 3rd parties. They take modiality scans of patients during the trial and send scans back to the drug company for study management.
The key challenges the companies have when trying to manage the trails evidence using medical images include:
- No single RIS / PACS are hospital centric, no workflow quality management solution
- Data Access and Control
- No easy access to data for follow up after initial work
- Scattered environment , prop images
- Data transfer
- No single standards, no audit trail, patient confidentially ,
- data
Novartis upgraded to 11g in 2008
Images are directed as an object in the DB. Its no longer a blob. Data does not need to be parses, so file infrastructure is not needed. The DB manages the archive as part its data life cycle.
Future a requirements is for the support of a flexible DICOM dictionary - managed through the database metadata service.
The development of a data quality rules through a XML schema. This would include image level rules, content of images, audit. This can then be brought
No comments:
Post a Comment